- Category
- Small (2022-23)
- Udyam number
- UDYAM-RJ-17-0000539

About D.D. Pharmaceuticals Pvt. Ltd
Data last updated:
D.D. Pharmaceuticals Pvt. Ltd is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 August 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1994PTC008661. Its GSTIN is 08AAACD4394D1ZS (Rajasthan).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹36.03 Lakh. It is led by directors including Lalita Choudhary (Whole-Time Director) and Amit Kumar Choudhary (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 1/583 RIICO Industrial Area Sitapura Tonk Road Jaipur. Sitapura Tonk Road Jaipur., Rajasthan, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹85.6 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹5.16 Cr (net margin 6%) and EBITDA of ₹10.38 Cr (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 19% over five years.
The company has about 252 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: DD Pharmaceuticals. As per MCA filings, the company has open charges of ₹24.64 Cr and satisfied charges of ₹30.52 Cr on record. Court records list 14 cases involving the company, including 4 filed by the company and 8 filed against it; 3 cases are pending.
D.D. Pharmaceuticals Pvt. Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0000539). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ddpharmapvtltd.com.
Recognitions & Rankings of D.D. Pharmaceuticals
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressG – 1/583 RIICO Industrial Area Sitapura Tonk Road Jaipur. Sitapura Tonk Road Jaipur., Rajasthan, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals operates one associated brand: DD Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets a wide range of healthcare products. | ddpharmapvtltd.com |
Business Activity of D.D. Pharmaceuticals Pvt. Ltd
The main business activity of D.D. Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of D.D. Pharmaceuticals Pvt. Ltd FY 2025 filings available
D.D. Pharmaceuticals Pvt. Ltd reported revenue of ₹85.6 Cr (up 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of D.D. Pharmaceuticals Pvt. Ltd
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 20% growth in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of D.D. Pharmaceuticals Pvt. Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.38 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.16 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of D.D. Pharmaceuticals Pvt. Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of D.D. Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalita Choudhary | Whole-Time Director | 12 Aug 1994 | 32 Years 2 Months | Current |
| Amit Kumar Choudhary | Whole-Time Director | 22 Jun 2001 | 25 Years 3 Months | Current |
| Alka Choudhary Also directs: Sarvam Global Healthcare LLP | Whole-Time Director | 10 Mar 2014 | 12 Years 7 Months | Current |
Peer Comparison of D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals Pvt. Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Safecon Lifesciences Private Limited | ₹87 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Agra, Uttar Pradesh, India |
| Health Biotech Limited | ₹86.89 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Chandigarh, India |
| Shree Maruti Nandan Pharmaceuticals Private Limited | ₹86.33 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Cyano Pharma Private Limited | ₹85.89 Cr (FY 2024) | •••• | •••• | 38.0% | •••• | Mumbai, Maharashtra, India |
| Zenara Pharma Private Limited | ₹85.73 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| D.D. Pharmaceuticals Pvt. Ltd this company | ₹85.6 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Jaipur, Rajasthan, India |
| Prachi Pharmaceuticals Private Limited | ₹85.43 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Hema Pharmaceuticals Pvt Ltd | ₹85.23 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ankleshwar, Gujarat, India |
| Sidmak Laboratories (India) Private Limited | ₹85.07 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Valsad, Gujarat, India |
| Nava Healthcare Private Limited | ₹84.21 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Solvate Laboratories Private Limited | ₹84.09 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below D.D. Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals Pvt. Ltd is audited by Bargoti Mantri & Company for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Bargoti Mantri & Company | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of D.D. Pharmaceuticals Pvt. Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of D.D. Pharmaceuticals Pvt. Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Others | ₹5.56 Cr | Open |
| 22 May 2024 | Others | ₹3.5 Cr | Open |
| 27 Jul 2021 | Others | ₹67.5 Lakh | Open |
| 27 Jun 2016 | Others | ₹14.9 Cr | Open |
| 03 Sep 2022 | Others | ₹12.9 Cr | Satisfied |
Total charge records: 12 View all charges
Legal Cases of D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals Pvt. Ltd has 14 court cases on record: 4 filed by D.D. Pharmaceuticals, 8 filed against it, 2 where it is another party. 3 cases are pending and 11 are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 7 | 2 |
| District courts | 2 | 1 | 1 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Appeal | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| Madras High Court | Civil suit | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| High Court of Andhra Pradesh | Court case (CRLP) | Filed by the company against State of Andhra Pradesh | Pending |
| District court, Guntur, Andhra Pradesh | Criminal complaint | Filed against the company by State of Ap | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against Principal Commissioner of Income-Tax (Central) Jaipur | Pending |
Full case history
All 14 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals Pvt. Ltd has a workforce of 252 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals Pvt. Ltd has 7 board changes on record since 1994: 3 appointments and 4 cessations. The latest: Alka Choudhary ceased to be Additional Director on 30 Sep 2014.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for D.D. Pharmaceuticals Pvt. Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by D.D. Pharmaceuticals Pvt. Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of D.D. Pharmaceuticals Pvt. Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACD4394D1ZS | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of D.D. Pharmaceuticals Pvt. Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about D.D. Pharmaceuticals Pvt. Ltd
D.D. Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 August 1994 (32+ years old) and is registered under CIN U24232RJ1994PTC008661.
D.D. Pharmaceuticals reported revenue of ₹85.6 Cr for FY 2024 (up 20% YoY).
D.D. Pharmaceuticals has 3 current directors:
- Lalita Choudhary - Whole-Time Director
- Amit Kumar Choudhary - Whole-Time Director
- Alka Choudhary - Whole-Time Director
D.D. Pharmaceuticals reported a net profit of ₹5.16 Cr (net margin 6%) and EBITDA of ₹10.38 Cr (EBITDA margin 12.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of D.D. Pharmaceuticals is 24% over three years and 19% over five years. In the latest year (FY 2024) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of D.D. Pharmaceuticals is 08AAACD4394D1ZS, registered in Rajasthan.
The CIN (Corporate Identification Number) of D.D. Pharmaceuticals is U24232RJ1994PTC008661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
D.D. Pharmaceuticals has 14 court cases on record: 4 filed by the company and 8 filed against it. 3 are pending. Most are in the high courts.
D.D. Pharmaceuticals was incorporated on 12 August 1994, making it 32+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of D.D. Pharmaceuticals by revenue are Safecon Lifesciences Private Limited, Health Biotech Limited, Shree Maruti Nandan Pharmaceuticals Private Limited, Cyano Pharma Private Limited, Zenara Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Alka Choudhary ceased to be Additional Director on 30 Sep 2014. Alka Choudhary was appointed as Whole-Time Director on 10 Mar 2014. Prakash Kumar Choudhary ceased to be Whole-Time Director on 23 Feb 2014. D.D. Pharmaceuticals has 7 board changes on record in total.